Anfield Capital Management, LLC Moderna, Inc. Transaction History

Anfield Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$118.38 - $210.04 $102,161 - $181,264	-863 Reduced 48.67%	910 $163,000
Q3 2022 Nov 09, 2022	BUY	$118.07 - $194.18 $7,438 - $12,233	63 Added 3.68%	1,773 $210,000
Q2 2022 Aug 09, 2022	BUY	$117.13 - $176.59 $29,516 - $44,500	252 Added 17.28%	1,710 $244,000
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $184,378 - $342,702	1,458 New	1,458 $251,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Anfield Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Anfield Capital Management, LLC with notifications on news.